Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutic implications

ESH eLearning, Oliver Hermine, 95253

Gene therapy in thalassaemia and sickle cell disease

ESH eLearning, Yves Beuzard, 95014

Bone marrow transplantation in thalassaemia and sickle cell disease, including haploidentical BMT

ESH eLearning, Alina Ferster, 95013

Guidelines for the biological diagnosis of haemoglobinopathies

ESH eLearning, C.L. Harteveld, 95012

Unstable haemoglobins: Physiopathology, clinical and biological diagnosis

ESH eLearning, Patricia Aguilar-Martinez, 95011

Laboratory diagnosis of abnormal haemoglobins, an update - From phenotype to genotype

ESH eLearning, Frederic Cotton, 95016

Sickle cell disease in adults and elderly patients: Emerging complications and management

ESH eLearning, Lucia De Franceschi, 95010

Sickle cell disease (SCD) in children and adolescents

ESH eLearning, Mariane de Montalembert, 95009

Alpha-thalassaemia: new fast test for the molecular diagnosis

ESH eLearning, C.L. Harteveld, 95008

Beta-thalassaemia: from CBC to DNA: methodologies and laboratory diagnosis

ESH eLearning, Patricia Aguilar-Martinez, 95007

Beta-thalassaemia: clinical findings, molecular defects genotype / phenotype relationship

ESH eLearning, Maria Domenica Cappellini, 95005

Recommendations for the recognition of centres of expertise on haemoglobinopathies in Europe

ESH eLearning, Joan-LLuis Vives-Corrons, 95004

Prevention programmes for thalassaemia and sickle cell disease: past and present

ESH eLearning, Michael Angastiniotis, 95003

Prevention of severe forms of haemoglobinopathies: Newmethodologies and procedures

ESH eLearning, Marina Kleanthous, 95001

Neonatal screening for sickle cell disease in European countries: where are we in 2015?

ESH eLearning, BEATRICE GULBIS, 95000

Migrations and haemoglobin disorders: current status in European countries

ESH eLearning, Maria del Mar MANU (Mañú), 94999

Introduction to the course

ESH eLearning, Patricia Aguilar-Martinez, 95252

Communication Skills

ESH eLearning, Session Speakers, 98455

Epidemiology of MDS and environmental factors

ESH eLearning, D. Bowen, 165409

Germline mutations predisposing to MDS

ESH eLearning, Brigitte Schlegelberger, 165410

Myelodysplastic stem cells

ESH eLearning, P. Woll, 165413

Cytogenetics

ESH eLearning, G. Göhring, 165415

Flow Cytometry in the Diagnostic Work-up of Myelodysplastic Syndromes

ESH eLearning, T. Westers, 165417

Molecular Biology

ESH eLearning, T. Haferlach, 165419

Prognosis and risk assessment

ESH eLearning, L. Malcovati, 165421

Predictive factors for response to treatment

ESH eLearning, R. Itzykson, 165423

Pathophysiology and treatment of anaemia in MDS

ESH eLearning, E. Hellström-Lindberg, 165424

Management of MDS with del(5q)

ESH eLearning, M. Jädersten, 165425

High risk MDS

ESH eLearning, L. Ades, 165426

Allogeneic HSCT

ESH eLearning, T. De Witte, 165427

Experimental transplantation approaches

ESH eLearning, N. Kröger, 165428

Apoptosis and erythroid differentiation

ESH eLearning, G. Courtois, 165650

Autophagy and erythroblast maturation

ESH eLearning, V. Betin, 165651

Epidemiology, pathophysiology and treatment of high altitude polycythemia (Monges’s disease)

ESH eLearning, J.P. Richalet, 165652

Large-scale erythroid differentiation using iPS cells

ESH eLearning, L. Douay, 165653

Not so benign haematology: anaemia of the elderly

ESH eLearning, C.N. Roy, 165654

Novel erythropoiesis-stimulating agents: a new era in anaemia management

ESH eLearning, I. Macdougall, 165655

Malaria: pathology and cytoadherence

ESH eLearning, A. Merckx, 165656

Modifier genes in sickle cell disease

ESH eLearning, J. Elion, 165657

Current diagnostics in- and classification of NHL, including demonstration of diagnostic pitfalls

ESH eLearning, A. Rosenwald, 165472

Staging and response evaluation, including the role of PET/CT scanning, including demonstration of pitfalls in imaging

ESH eLearning, M. Hutchings, 165473

Treatment options, including clinical cases, controversies

ESH eLearning, A. Hagenbeek, 165474

Treatment options, including clinical cases, controversies

ESH eLearning, M. Dreyling, 165475

Current diagnostics and staging of MM, including demonstration of diagnostic pitfalls

ESH eLearning, H. Goldschmidt, 165476

Stratification and response evaluation, including demonstration of pitfalls

ESH eLearning, H. Avet-Loiseau, 165477

Treatment options, including clinical cases, controversies

ESH eLearning, M.V. Mateos, 165478

Treatment options, including clinical cases, controversies

ESH eLearning, G. Merlini, 165479

State of the art including methods for graft facilitation

ESH eLearning, H.E. Broxmeyer, 165531

Cord blood subpopulations and reprogrammed cells

ESH eLearning, G. Koegler, 165532

State of the art

ESH eLearning, E.J. Shpall, 165533

Hematopoietic stem cell expansion to overcome non-engraftment

ESH eLearning, J. Wagner, 165534

The present and future challenges of gene therapy for sickle cell disease

ESH eLearning, F. Mavilio, 165535

Biomarker – based personalized medicine

ESH eLearning, S. Paczesny, 165536

Tregs for immune modulation

ESH eLearning, J. Wagner, 165537

Assesment of HLA diversity in Marseille cord blood bank

ESH eLearning, C. Chabannon, 165538

Human cord blood (CB) derived unrestricted somatic stem cells (USSCS) significantly improves survival and wound healing in an animal model of recessive dystrophic epidermolysis bullosa (RDEB)

ESH eLearning, M. Cairo, 165539

Crosstalk between umbilical cord/cord blood endothelial precursors and mesenchymal stromal cells in promoting new blood vessel formation

ESH eLearning, S. Watt, 165540

Treatment of mesenchymal stromal cells with immunosuppressive drugs increases their immunoregulatory potency

ESH eLearning, J. Girdlestone, 165541

The Italian Cord Blood Platelet Gel project

ESH eLearning, P. Rebulla, 165542

Increasing use of hematopoietic stem cell transplantation for ethnic minorities

ESH eLearning, M. Oudshoorn, 165543

Role of non HLA markers for donor selection

ESH eLearning, R. Tamouza, 165544

State of the art

ESH eLearning, E. Baudoux, 165545

Updating the cord blood unit inventory to meet current needs

ESH eLearning, S. Querol, 165546

Role of registries to analyze outcomes data – Eurocord – Netcord

ESH eLearning, V. Rocha, 165547

Sickle cell disease global perspective

ESH eLearning, E. Gluckman, 165548

Is sickle cell disease an autonomic nervous system disorder: what triggers the transition from steady state to crisis?

ESH eLearning, T. Coates, 165549

Haplo-identical related hematopoietic stem cell transplant for sickle cell disease

ESH eLearning, R. Jones, 165550

Epidemiology and treatment of sickle cell in Senegal including hydroxycarbamide, transfusions and chelation in children

ESH eLearning, I. Diagne, 165551

State of the art

ESH eLearning, J. Wagner, 165552

Results of single and double cord blood in adult malignancies: cost efficiency study

ESH eLearning, A. Ruggeri, 165553

Conditioning for cord blood transplant

ESH eLearning, G. Sanz, 165554

Cord blood transplant in children with non malignant disease

ESH eLearning, E. Gluckman, 165555

Cord blood transplantation for adults: what have we learned

ESH eLearning, D. Weisdorf, 165556

Unrelated donor umbilical cord blood transplantation (UCBT) for hemoglobinopathy using reduced intensity conditioning (RIC)

ESH eLearning, A. Abraham, 165557

Outcome analysis of unrelated cord blood transplantation in Korea

ESH eLearning, Y.H. Lee, 165558

Allogeneic hematopoietic stem cell transplantation (HSCT) for treatment of high risk hemoglobinopathy patients lacking a fully HLA-matched sibling donor using a novel myeloablative, reduced toxicity conditioning regimen

ESH eLearning, S. Kharbanda, 165559

Haplo versus cord blood: pros cord blood

ESH eLearning, J. Wagner, 165560

Algorythm of donor choice

ESH eLearning, K. Ballen, 165561

The RTN Policy: a comprehensive algorythm of the allogeneic hematopoietic stem cell transplant for adults with hematological malignancies

ESH eLearning, W. Arcese, 165562

Networks, research tools and cooperation: the example of network research on sickle cell disease in Central Africa

ESH eLearning, L. Tshilolo, 165563

Problems related to the availability of opioids in Africa

ESH eLearning, E. Kafando, 165564

Association for the struggle against sickle cell disease in Niger

ESH eLearning, F. Hima, 165565

Struggle against sickle cell disease Madagascar-France

ESH eLearning, P. Jeannot, 165566

Support association for SCD in Mauritania

ESH eLearning, M. Wane, 165567

Senegalese Association for the struggle against Sickle Cell Disease

ESH eLearning, M. Ndiaye, 165568

Waldenstrom macroglobulinemia

ESH eLearning, Enrica Morra, 38714

Smouldering Myeloma

ESH eLearning, María-Victoria Mateos, 38710

MGUS

ESH eLearning, Shaji Kumar, 38705

Role of Allo

ESH eLearning, Henk Lokhorst, 38707

Role of consolidation / maintenance

ESH eLearning, M Mohty, 38697

Stratification for risk or age

ESH eLearning, Michele Cavo, 38699

Treatment of relapse

ESH eLearning, Michel Delforge, 38701

Treatment of fit elderly patients

ESH eLearning, Antonio Palumbo, 38718

Treatment of younger patients

ESH eLearning, Pieter Sonneveld, 38720

Histone deacetylase

ESH eLearning, Enrique Ocio, 38716

Monoclonal antibodies

ESH eLearning, Sagar LONIAL, 38708

Pomalidomide

ESH eLearning, Thierry Facon, 38702

Carfilzomib

ESH eLearning, Keith Stewart, 38721

MLN9708

ESH eLearning, Roman Hajek, 38703